Cydan

Cydan is an orphan drug accelerator that identifies compounds with therapeutic and commercial potential and mitigates risks. Their rigorous process generates data to support development pathways and the formation of new companies. Cydan’s experienced, globally networked team has built strong relationships with academia and patient advocates, possesses deep expertise in drug development, and has a proven track record of successful product commercialization.